SCHEMBL30079417

SCHEMBL30079417

COc1nccc(C(F)(F)F)c1N1CCC(=O)CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 2/20 0.42
SLC22A12 Q96S37 1/20 0.35
NFE2L2 Q16236 2/20 0.34
HSD11B1 P28845 1/20 0.34
TRPV1 Q8NER1 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
HCRTR2 O43614 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32
ITGAL P20701 1/20 0.32
LMNA P02545 2/20 0.32
NCF1 P14598 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
PHGDH O43175 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30079304 0.80 C5AR1 (0.41) C5AR1PIK3CAALDH1A1LMNAMAPT
SCHEMBL30079400 0.80 C5AR1 (0.44) C5AR1ITGB2ICAM1ITGAL
SCHEMBL30079321 0.79 SUV39H2 (0.35) NFE2L2ALDH1A1LMNAMAPT
SCHEMBL30079447 0.77 ALDH1A1 (0.39) C5AR1ALDH1A1LMNAMAPTHTT
SCHEMBL31266352 0.70 SLC2A1 (0.46) LMNAMAPT
SCHEMBL24246943 0.69 SLC22A12 (0.44) SLC22A12NFE2L2
SCHEMBL9280550 0.68 SLC22A12 (0.40) SLC22A12NFE2L2
SCHEMBL13415859 0.68 SLC22A12 (0.40) SLC22A12NFE2L2ALDH1A1
SCHEMBL1369593 0.67 EPHX2 (0.66) HSD11B1LMNAMAPTHTT
SCHEMBL677137 0.66 SLC22A12 (0.40) SLC22A12NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 EP disclosed